Celosome Strong HA Injection
Medically Reviewed
ISO 13485 Facility
Clinical Grade
Core Specifications
HA Concentration
24 mg/ml
Lidocaine HCl
0.3%
Target Depth
Mid-Deep Dermis
Clinical Duration
12 – 24 Months
8-Step Purification Metrics
BDDE Residue
< 0.5 ppm
Endotoxin Level
< 0.05 EU/ml
Heavy Metals
< 10 ppm
pH Level
6.8 – 7.5
HENM™ Cross-Linking Technology
Proprietary Hyaluronic Engineering Network Matrix maximizes viscoelasticity while minimizing chemical modification.
Elasticity Modulus (G′)
350 – 450 Pa
Viscosity Modulus (G″)
50 – 70 Pa
Phase Angle
< 9.0° (High Cohesivity)
Degradation Resistance
+40% vs Standard HA
Clinical Injection Protocol
Hardware & Volume
1.1ml Luer-Lock Syringe. 27G½ Ultra-Thin Wall Needle. Max tolerance: 0.2ml/cm² tissue area.
Technique
Linear retrograde administration. 2.0mm – 4.0mm insertion depth. 3-5 minute post-injection molding required.
YMYL Compliance & Safety Disclaimer
For administration by licensed medical practitioners only. Contraindicated for pregnant/breastfeeding women, individuals with severe allergies, porphyria, or active autoimmune conditions. Data accuracy ±15% based on patient metabolic factors. Report adverse events within 24 hours to [email protected].


Emma Carter –
Our nurses say the lidocaine mixture makes the injection process smoother and clients experience little discomfort. And, we’ve seen clients with Celosome Strong have jawlines that are still visible eight months later.
Johnson –
When my dermatologist injected Celosome Strong, I felt much less pain than I expected due to the lidocaine. To be honest, my laugh lines started to fade noticeably after a few days. It’s been four months now and my face looks fuller, but no one has noticed I had the procedure.